Anna Palejko

Anna Palejko

Auto-generated profile, based on publicly available information

Anna Palejko

2nd Department of Neurology Institute of Psychiatry and Neurology Warsaw Poland

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2022 in JIMD Reports
Verified
Journal Article
Open access
MAMagdalena Antczak‐Kowalska
Magdalena Antczak‐Kowalska
ACAnna Czlonkowska
Anna Czlonkowska
CECeren Eyileten
Ceren Eyileten
APAnna Palejko
Anna Palejko
ACAgnieszka Cudna
Agnieszka Cudna
Tomasz LitwinTomasz Litwin
Tomasz Litwin
Symptoms of Wilson disease (WD) vary and additional factors such as autoimmunity may play an important role in WD pathogenesis. The presence of antinuclear antibodies (ANA), anti‐neutrophil cytoplasmic antibodies, neuronal surface antibodies, and onconeural antibodies in WD was investigated using standardized indirect immunofluorescence assays and Western Blot analysis. The presence of all studied autoantibodies was higher in WD patients in comparison to healthy subjects, but there was no statistically significant difference in autoantibodies frequency according to disease manifestation. D‐penicillamine treatment was associated with a higher presence of ANA than zinc sulfate but without an increase in autoimmune diseases rate.